← Open Payments lookup

VI PHAN: Open Payments

NPI 1386287514 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,493 in 58 payments from 14 companies in 2025. Trend: 2023 $636 · 2024 $1,707 · 2025 $1,493

Food & beverage: $1,493
CompanyPaymentsAmount
Abbott Laboratories6$443
Novartis Pharmaceuticals Corporation8$219
BridgeBio Pharma, Inc.8$159
AstraZeneca Pharmaceuticals LP8$142
Amgen Inc.9$135
Esperion Therapeutics, Inc.6$96
Novo Nordisk Inc3$71
Alnylam Pharmaceuticals Inc.2$60
E.R. Squibb & Sons, L.L.C.2$44
SCPHARMACEUTICALS INC.2$35

Products named: CARDIOMEMS, LEQVIO, Attruby, FARXIGA, REPATHA, NEXLETOL, Wegovy, AMVUTTRA.

Industry payments across TX — which companies pay providers there.